Biogen IncImpact on stocks 5
Biogen Inc
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
GSK plc
CTO Realty Growth IncMore than 450 executives from over 100 leading life sciences organizations gathered at Axtria Ignite 2026 in Princeton, New Jersey, where founder and CEO Jaswinder Chadha delivered a contrarian message: fix the foundation before scaling AI. Chadha highlighted that roughly 73% of biopharma still reports significant data issues, as many as 89% of AI pilots never reach production, and trust in AI systems has slipped from 61% in 2019 to 53% today, even as the industry races toward a projected 100,000-plus AI agents. He outlined four foundational requirements: an AI-ready data supply chain, a semantic layer for agent accuracy, software guardrails for deterministic precision, and a governance framework for digital workers at scale. The event also featured candid discussions on CFO-certifiable business value and change management, with one senior leader noting that adoption of AI at her company now stands at over 90% after framing it as a people revolution rather than an AI revolution. The Ignite Leadership Awards honored transformation leaders from Bristol Myers Squibb, GSK, and Biogen, while the Axtria Bedrock Honor recognized a 15-year partnership with Quest Diagnostics for implementing a complex sales force alignment solution across 34 role types and a roughly 1,300-person field organization.
Biogen Inc
Bristol-Myers Squibb Company
Quest Diagnostics Incorporated
GSK plc
CTO Realty Growth Inc